Saturday 17 October 2026
Export HYFT’s income statement to Excel — free account
MindWalk Holdings Corp.
HYFT Healthcare Biotechnology
MindWalk Holdings Corp.’s revenue for fiscal 2026 (year ended April 2026) was $11.3 million, down 35.9% from fiscal 2025. In the quarter to July 2026, revenue grew 19.4%, EPS fell 80.0%, free cash flow grew 9.79% and total debt fell 10.8%, each against the same quarter a year earlier.
1.31
0.09
−6.43%
Follow HYFT
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 3 |
| (116.44%) | (63.81%) | (79.38%) | (122.85%) | ||
| (68.11%) | (37.27%) | (42.67%) | (58.55%) | ||
ROIC |
(164.31%) | (195.33%) | (269.05%) | (464.59%) | |
Return on Tangible Assets |
(142.81%) | (70.53%) | (96.35%) | (179.65%) | |
Average Days of Receivables |
59.16 | 41.31 | 70.40 | 52.80 | |
Free Cash Flow per Share |
(0.16) | (0.19) | (0.20) | (0.19) | |
Free Cash Flow |
(7.31) | (8.69) | (9.32) | (9.00) | |
Capital Expenditures |
(0.59) | (0.54) | (0.29) | (0.14) | |
| Other line items | |||||
Cash ROIC |
(27.13%) | (37.61%) | (49.15%) | (71.66%) | |
Accounts Receivable Turnover |
5.23 | 6.36 | 4.31 | 7.32 | |
Accounts Payable Turnover |
1.88 | 1.91 | 1.36 | 1.46 | |
Inventory Turnover |
6.50 | 6.15 | 5.00 | 11.22 | |
Average Days of Payables |
149.83 | 167.59 | 237.91 | 309.74 | |
Days of Inventory on Hand |
23.18 | 24.63 | 28.02 | 34.78 | |
Tax Rate |
(0.08) | 0.01 | (0.03) | (0.01) | |
Research and Development Expense of Revenue |
21.65% | 24.83% | 31.71% | 31.84% | |
Selling, General and Administrative Expense of Revenue |
90.80% | 100.69% | 123.10% | 132.96% | |
Share Based Compensation of Revenue |
1.60% | 2.87% | 8.20% | 12.07% | |
Operating CF/Net income |
0.31 | 0.90 | 0.89 | 0.72 | |
Depreciation/Fixed assets |
0.81 | 0.59 | 0.40 | 0.23 | |
Capex/Depreciation |
(0.24) | (0.32) | (0.25) | (0.21) | |
Revenue per Share |
0.31 | 0.28 | 0.24 | 0.25 | |
Operating CF per Share |
(0.15) | (0.18) | (0.19) | (0.19) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.01 |
Columns are period end dates · fundamentals updated 2 Oct 2026